Physician profile
Sally Thomas
NPI 1538197009
$1,200.46
in general payments reported to CMS, 2019-2025
16 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2021: $131 · 2022: $215 · 2024: $73.72 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $256.81 | 2019-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $241.73 | 2021-2024 | |
| Teleflex LLC | $209.63 | 2025 | Urolift |
| Lilly USA, LLC | $111.90 | 2019-2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $93.29 | 2019-2025 | Farxiga, Airsupra |
| Pfizer INC. | $58.01 | 2019-2025 | |
| Shire North American Group INC | $56.19 | 2019 | |
| Medtronic, INC. | $25.22 | 2025 | Venaseal |
| Hologic Sales and Service, LLC | $24.16 | 2024 | Aptima, Thinprep 2000 Processor |
| Optinose US, INC. | $20.67 | 2025 | |
| Exact Sciences Corporation | $20.01 | 2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $18.95 | 2019 | |
| Tolmar, INC. | $18.66 | 2025 | Jatenzo |
| Zyla Life Sciences, INC. | $16.24 | 2019 | |
| Glaxosmithkline, LLC. | $15.00 | 2025 | Arexvy, Shingrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.